These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19432115)

  • 1. [Risedronate for treatment of osteoporosis].
    Hagino H
    Nihon Rinsho; 2009 May; 67(5):948-53. PubMed ID: 19432115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differences among bisfosfonates--specificity of risedronate (Actonel)].
    Giljević Z
    Reumatizam; 2008; 55(2):78-80. PubMed ID: 19024283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerability of risedronate for the treatment of osteoporosis].
    Kishimoto H
    Clin Calcium; 2008 Oct; 18(10):1417-26. PubMed ID: 18830038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risedronate for the prevention of fractures in postmenopausal osteoporosis.
    Sickels JM; Nip CS
    Ann Pharmacother; 2002 Apr; 36(4):664-70. PubMed ID: 11918518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.
    Bilezikian JP
    Am J Med; 2009 Feb; 122(2 Suppl):S14-21. PubMed ID: 19187808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of anti-resorptive drugs for the treatment of osteoporosis].
    Takada J
    Nihon Rinsho; 2006 Feb; 64(2):385-91. PubMed ID: 16454196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.
    Boonen S; Laan RF; Barton IP; Watts NB
    Osteoporos Int; 2005 Oct; 16(10):1291-8. PubMed ID: 15986101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of osteoporosis by risedronate-- speed, efficacy and safety].
    Giljević Z; Vlak T
    Reumatizam; 2006; 53(2):66-71. PubMed ID: 17580558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.
    Bobba R; Adachi JD
    Clin Interv Aging; 2007; 2(3):275-82. PubMed ID: 18044178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy.
    Kanaji A; Higashi M; Namisato M; Nishio M; Ando K; Yamada H
    Lepr Rev; 2006 Jun; 77(2):147-53. PubMed ID: 16895071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in older people: a tale of two studies (and three treatments).
    Troen BR
    J Am Geriatr Soc; 2006 May; 54(5):853-5. PubMed ID: 16696755
    [No Abstract]   [Full Text] [Related]  

  • 15. When do bisphosphonates make the most sense?
    Winzenberg T; Jones G
    J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study.
    Ringe JD; Faber H; Farahmand P; Dorst A
    Rheumatol Int; 2006 Mar; 26(5):427-31. PubMed ID: 16001181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.
    Ringe JD; Farahmand P; Faber H; Dorst A
    Rheumatol Int; 2009 Jan; 29(3):311-5. PubMed ID: 18762944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonates in the prevention of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis].
    Curković B
    Reumatizam; 2003; 50(2):49-50. PubMed ID: 15098377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.